Lab ID	Data Source	Collection Site Code	Gender	Ethnicity	Race	Smoking Status	Pack Years	Vital Status	Stage at Dx	Overall Survival (months)	Procedure Type	Tissue Type	Site	Histology	Treatment Status	Pre-collection Therapies	Time between last drug administration and tissue collection (months)	IO line of therapy	Pre-Tissue IO Type	Clinical ASCL1	Clinical NeuroD1	ASCL1	NeuroD1	YAP1	POU2F3
Ru325	Current manuscript	PL	Female	Non-Spanish; Non-Hispanic                         	White	Never	0	Deceased	IV	35.7	Pleural Fluid	Metastasis	Lung Pleura	Alternating Small Cell Lung Carcinoma and Lung Adenocarcinoma	Treated	carboplatin+etoposide; ipilimumab+nivolumab; temozolmide; oral etoposide; pemetrexed+bevacizumab; oral topotecan; gemcitabine; temozolomide; paclitaxel	0.2	2L	combination ICB						
RU1038	Current manuscript	T	Female	Non-Spanish; Non-Hispanic                         	White	Never	0	Alive	IA	21	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU1057	Current manuscript	T	Female	Non-Spanish; Non-Hispanic                         	White	Former	30	Alive	IIB	21.4	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU1061	Current manuscript	T	Female	Non-Spanish; Non-Hispanic                         	White	Current	37.5	Alive	IV	21.8	Resection	Primary	Lung	Adenosquamous Carcinoma	Naïve	NA	n/a	na	na						
RU1065C	Current manuscript	LI	Female	Non-Spanish; Non-Hispanic	White	Current	20	Deceased	IV	10.4	Biopsy	Metastasis	Liver	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide+atezolizumab	0.7	1L	combination chemo-IO	NA	NA	pos	neg	neg	neg
RU1066	Current manuscript	T	Female	Non-Spanish; Non-Hispanic                         	White	Former	40	Alive	IB	16.3	Resection	Primary	Lung	Small Cell Lung Carcinoma	Naïve	NA	n/a	na	na						
RU1080	Current manuscript	KID	Female	Non-Spanish; Non-Hispanic	White	Former	12.5	Alive	IV	17.1	Resection	Metastasis	Kidney	Small Cell Lung Carcinoma	Treated	cisplatin+etoposide+atezolizumab	0.8	1L	combination chemo-IO						
RU1108a	Current manuscript	R	Female	Non-Spanish; Non-Hispanic                         	White	Current	5	Alive	IIIA	81.4	Resection	Recurrence	Lung	Small Cell Lung Carcinoma	Treated	cisplatin+etoposide; carboplatin+etoposide; temozolomide+/-ABT888; temozolomide alone; temozolomide rechallenge	32.4	5L	combination ICB						
RU1128	Current manuscript	T	Female	Non-Spanish; Non-Hispanic                         	White	Former	2.6	Alive	IA	17.4	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU1134	Current manuscript	T	Male	Non-Spanish; Non-Hispanic                         	White	Former	25.5	Alive	IIB	21.8	Resection	Primary	Lung	Lung Adenocarcinoma	Treated	carboplatin+pemetrexed	1.6	na	na						
RU1135	Current manuscript	T	Male	Non-Spanish; Non-Hispanic                         	White	Current	45	Alive	IIIA	13.8	Resection	Primary	Lung	Lung Adenocarcinoma	Treated	atezolizumab	0.7	neoadjuvant	monotherapy						
RU1137	Current manuscript	T	Female	Non-Spanish; Non-Hispanic                         	White	Current	32.9	Deceased	IIB	11.4	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	1L	monotherapy						
RU1138	Current manuscript	LI	Male	Non-Spanish; Non-Hispanic                         	African American	Former	10.5	Alive	IV	33.6	Biopsy	Metastasis	Liver	Lung Adenocarcinoma	Treated	pembrolizumab; osimertinib; carboplatin+pemetrexed	0.2	1L	monotherapy						
RU1144_T	Current manuscript	R	Female	Non-Spanish; Non-Hispanic                         	White	Former	60	Alive	IA	54.1	Resection	Recurrence	Lung	Small Cell Lung Carcinoma	Treated	cis-carboplatin+etoposide	35.2	na	na	pos	neg	pos	few scattered pos cells	neg	neg
RU1144_LN	Current manuscript	LN	Female	Non-Spanish; Non-Hispanic                         	White	Former	60	Alive	IA	54.1	Biopsy	Metastasis	Lymph Node	Small Cell Lung Carcinoma	Treated	cis-carboplatin+etoposide	35.2	na	na						
RU1145	Current manuscript	T	Male	Non-Spanish; Non-Hispanic                         	White	Former	40	Alive	IB	17.8	Resection	Primary	Lung	Small Cell Lung Carcinoma	Naïve	NA	n/a	na	na	neg	pos (focal)	pos	pos (focal)	neg	neg
RU1152	Current manuscript	LN	Male	Non-Spanish; Non-Hispanic                         	White	Current	51	Alive	IV	16.6	Biopsy	Metastasis	Lymph Node	Small Cell Lung Carcinoma	Naïve	NA	n/a	1L	combination chemo-IO						
RU1170	Current manuscript	T	Male	Non-Spanish; Non-Hispanic	White	Never	0	Alive	IIIB	16.8	Biopsy	Primary	Lung	Lung Adenocarcinoma	Treated	cisplatin+pemetrexed	1.2	na	na						
RU1181_LN	Current manuscript	LN	Male	Non-Spanish; Non-Hispanic	White	Former	12	Deceased	IIIA	42.9	Biopsy	Metastasis	Lymph Node	Small Cell Carcinoma	Treated	cisplatin+etoposide	1.1	na	na						
RU1181_T	Current manuscript	T	Male	Non-Spanish; Non-Hispanic	White	Former	12	Deceased	IIIA	3.1	Resection	Primary	Lung	Combined Small Cell Lung Carcinoma + Adenocarcinoma	Treated	cisplatin+etoposide	1.1	na	na						
RU1195A	Current manuscript	R	Male	Non-Spanish; Non-Hispanic	Chinese	Current	22.5	Deceased	IIA	38.8	Resection	Recurrence	Lung	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide; carboplatin+etoposide (rechallenge); ipilimumab+nivolumab	0.6	3L	combination ICB	NA	NA	pos	pos	neg	neg
RU1215	Current manuscript	PL	Female	Non-Spanish; Non-Hispanic	White	Current	60	Alive	IV	6.9	Pleural Fluid	Metastasis	Lung Pleura	Small Cell Lung Carcinoma	Naïve	NA	n/a	1L	combination chemo-IO						
RU1229A	Current manuscript	T	Female	Non-Spanish; Non-Hispanic	White	Current	25	Alive	IB	11.4	Resection	Primary	Lung	Small Cell Lung Carcinoma	Naïve	NA	n/a	na	na	pos	neg	pos (focal)	few scattered pos cells	pos (focal), stroma pos	neg
RU1231A	Current manuscript	LN	Male	Non-Spanish; Non-Hispanic	White	Former	30	Alive	IIB	13	Biopsy	Primary	Lymph Node	Small Cell Lung Carcinoma	Naïve	NA	n/a	na	na						
RU1262C	Current manuscript	T	Female	Non-Spanish; Non-Hispanic	White	Former	7.5	Alive	IIB	13.4	Resection	Primary	Lung	Lung Adenocarcinoma	Treated	carboplatin+pemetrexed	1.1	na	na						
RU1271	Current manuscript	T	Male	Non-Spanish; Non-Hispanic	White	Current	62	Alive	IV	10.9	Biopsy	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	2L	monotherapy						
RU1293A	Current manuscript	LN	Male	Non-Spanish; Non-Hispanic	White	Current	37	Deceased	IV	6.3	Biopsy	Metastasis	Lymph Node	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide+atezolizumab	2.2	1L	combination chemo-IO						
Ru1311	Current manuscript	R	Female	Non-Spanish; Non-Hispanic	White	Former	60	Alive	IA	40.7	Biopsy	Recurrence	Lung	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide	28.2	na	na						
Ru1322	Current manuscript	LN	Male	Non-Spanish; Non-Hispanic	White	Never	0	Alive	IV	20.1	Biopsy	Metastasis	Lymph Node	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide; ipilimumab+nivolumab	0	2L	combination ICB						
RU255	Laughney et al., Nature Medicine 2020	CNS	Female	Non-Spanish; Non-Hispanic	White	Former	27	Alive	IIB	60.4	Biopsy	Metastasis	Brain	Lung Adenocarcinoma	Treated	cisplatin+vinorelbine	16.5	na	na						
RU653	Laughney et al., Nature Medicine 2020	T	Female	Non-Spanish; Non-Hispanic	Asian-Far East/Indian Subcont	Never	0	Alive	IA	38.8	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU661	Laughney et al., Nature Medicine 2020	T	Female	Non-Spanish; Non-Hispanic	White	Former	30	Alive	IA	41.3	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU666	Laughney et al., Nature Medicine 2020	B	Male	Non-Spanish; Non-Hispanic	Asian-Far East/Indian Subcont	Never	0	Deceased	IV	14.2	Biopsy	Metastasis	Bone	Lung Adenocarcinoma	Treated	afatinib; carboplatin+pemetrexed	0.8	na	na						
RU675	Laughney et al., Nature Medicine 2020	T	Female	Non-Spanish; Non-Hispanic	Asian-Far East/Indian Subcont	Never	0	Alive	IV	10	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU676	Laughney et al., Nature Medicine 2020	T	Female	Non-Spanish; Non-Hispanic	White	Current	40	Alive	IB	42	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU681	Laughney et al., Nature Medicine 2020	CNS	Female	Non-Spanish; Non-Hispanic	White	Current	63	Deceased	IIIA	72	Biopsy	Metastasis	Brain	Lung Adenocarcinoma	Treated	cisplatin+vinorelbine	42.7	na	na						
RU682	Laughney et al., Nature Medicine 2020	T	Male	Non-Spanish; Non-Hispanic	White	Former	100	Alive	IA	37.8	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU684	Laughney et al., Nature Medicine 2020	T	Female	Non-Spanish; Non-Hispanic	White	Current	15	Alive	IA	32.6	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU685	Laughney et al., Nature Medicine 2020	T	Male	Non-Spanish; Non-Hispanic	White	Never	0	Alive	IA	40.7	Resection	Primary	Lung	Lung Adenocarcinoma	Naïve	NA	n/a	na	na						
RU699	Laughney et al., Nature Medicine 2020	AD	Female	Non-Spanish; Non-Hispanic	White	Former	3.2	Alive	IV	39.7	Resection	Metastasis	Adrenal	Lung Adenocarcinoma	Treated	carboplatin+paclitaxel; tremelimumab+durvalumab; nivolumab	2.7	2L, 3L	combination ICB, monotherapy						
RU701	Laughney et al., Nature Medicine 2020	CNS	Male	Non-Spanish; Non-Hispanic	White	Never	0	Deceased	IIIA	59.2	Biopsy	Metastasis	Brain	Lung Adenocarcinoma	Treated	carboplatin+pemetrexed; erlotinib	0.3	na	na						
RU779	Current manuscript	LI	Male	Non-Spanish; Non-Hispanic	White	Former	17.5	Deceased	IV	26.3	Biopsy	Metastasis	Liver	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide +/- pembrolizumab; ipilimumab+nivolumab; temozolomide; DS-3201b+irinotecan	n/a	1L, 2L	combination chemo-IO, combination ICB	NA	NA	few scattered pos cells	pos	neg	neg
RU831	Current manuscript	CNS	Female	Non-Spanish; Non-Hispanic	White	Never	0	Deceased	IV	7.8	Biopsy	Metastasis	Brain	Small Cell Lung Carcinoma	Treated	cisplatin+etoposide	0.7	2L	combination ICB						
RU426	Current manuscript	T	Female	Non-Spanish; Non-Hispanic	White	Current	52.5	Deceased	IIIA	6.3	Resection	Primary	Lung	Small Cell Lung Carcinoma	Naïve	NA	n/a	2L	monotherapy	pos	pos (focal)				
RU1124	Current manuscript	LN	Female	Spanish NOS; Hispanic NOS, Latino NOS            	White	Former	12	Deceased	IV	8.2	Biopsy	Metastasis	Lymph Node	Small Cell Lung Carcinoma	Treated	carboplatin+etoposide+atezolizumab	0.5	1L	combination chemo-IO						

